Peak Width of Skeletonized Mean Diffusivity: A Neuroimaging Marker for White Matter Injury.
暂无分享,去创建一个
A. Charidimou | M. Duering | A. Viswanathan | M. Etherton | P. Yilmaz | D. Schoemaker | Susanne J. van Veluw | L. Sveikata | M.C. Zanon Zotin | S. Greenberg
[1] Lauren E. Oberlin,et al. Late-life depression accentuates cognitive weaknesses in older adults with small vessel disease , 2021, Neuropsychopharmacology.
[2] C. Gerloff,et al. White matter integrity and structural brain network topology in cerebral small vessel disease: The Hamburg city health study , 2020, Human brain mapping.
[3] Nick A. Weaver,et al. Small vessel disease more than Alzheimer's disease determines diffusion MRI alterations in memory clinic patients , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.
[4] P. Sachdev,et al. Plasma lipidomic biomarker analysis reveals distinct lipid changes in vascular dementia , 2020, Computational and structural biotechnology journal.
[5] C. Gerloff,et al. Network Localisation of White Matter Damage in Cerebral Small Vessel Disease , 2020, Scientific Reports.
[6] Eric E. Smith,et al. Cross-sectional and longitudinal differences in peak skeletonized white matter mean diffusivity in cerebral amyloid angiopathy , 2020, NeuroImage: Clinical.
[7] J. O'Brien,et al. Peak Width of Skeletonized Mean Diffusivity as a Marker of Diffuse Cerebrovascular Damage , 2020, Frontiers in Neuroscience.
[8] I. Deary,et al. Age-Related Changes of Peak Width Skeletonized Mean Diffusivity (PSMD) Across the Adult Lifespan: A Multi-Cohort Study , 2020, bioRxiv.
[9] W. Chu,et al. Peak width of skeletonized mean diffusivity and its association with age-related cognitive alterations and vascular risk factors , 2019, Alzheimer's & dementia.
[10] Stuart J. Ritchie,et al. Brain Peak Width of Skeletonized Mean Diffusivity (PSMD) and Cognitive Function in Later Life , 2019, Front. Psychiatry.
[11] K. Kapur,et al. Reproducibility of Structural and Diffusion Tensor Imaging in the TACERN Multi-Center Study , 2019, Front. Integr. Neurosci..
[12] R. Steele,et al. Estimating the sample mean and standard deviation from commonly reported quantiles in meta-analysis , 2019, Statistical methods in medical research.
[13] Richard Frayne,et al. Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration , 2019, Alzheimer's & dementia.
[14] L. Yao,et al. A Neuroimaging Marker Based on Diffusion Tensor Imaging and Cognitive Impairment Due to Cerebral White Matter Lesions , 2019, Front. Neurol..
[15] Rajikha Raja,et al. Review of diffusion MRI studies in chronic white matter diseases , 2019, Neuroscience Letters.
[16] Sridar Narayanan,et al. Scan-rescan repeatability and cross-scanner comparability of DTI metrics in healthy subjects in the SPRINT-MS multicenter trial. , 2018, Magnetic resonance imaging.
[17] Martin Rossor,et al. White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer’s disease , 2018, Brain : a journal of neurology.
[18] Mark E Bastin,et al. Ageing and brain white matter structure in 3,513 UK Biobank participants , 2016, Nature Communications.
[19] R. Fields,et al. White matter and cognition: making the connection. , 2016, Journal of neurophysiology.
[20] F. de Leeuw,et al. A Novel Imaging Marker for Small Vessel Disease Based on Skeletonization of White Matter Tracts and Diffusion Histograms , 2016, Annals of neurology.
[21] S. Greenberg,et al. Ischemic brain injury in cerebral amyloid angiopathy , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[22] D. Auer,et al. Multi-centre reproducibility of diffusion MRI parameters for clinical sequences in the brain , 2015, NMR in biomedicine.
[23] Benjamin S. Aribisala,et al. White matter hyperintensities and normal-appearing white matter integrity in the aging brain , 2015, Neurobiology of Aging.
[24] Á. Gil,et al. Are healthcare workers’ intentions to vaccinate related to their knowledge, beliefs and attitudes? a systematic review , 2013, BMC Public Health.
[25] C. Lebel,et al. Diffusion tensor imaging of white matter tract evolution over the lifespan , 2012, NeuroImage.
[26] Elizabeth Fisher,et al. Multiple sclerosis normal‐appearing white matter: Pathology–imaging correlations , 2011, Annals of neurology.